Clinical Trial Update: Clinical Trial of Mica [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial of Mica for latent tuberculosis infection, indicating the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Drugs mentioned

• Mica

Snippet

Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Conditions: Latent Tuberculosis Infection | Phase 4 | Status: ACTIVE_NOT_RECRUITING